Gene Therapy Revolution: Waskyra Offers Life-Changing Hope for Wiskott-Aldrich Syndrome Patients

A groundbreaking achievement in genetic medicine has emerged as the European Medicines Agency (EMA) recommended approval of Waskyra (etuvetidigene autotemcel), the first gene therapy specifically designed to treat Wiskott-Aldrich syndrome…

Continue Reading Gene Therapy Revolution: Waskyra Offers Life-Changing Hope for Wiskott-Aldrich Syndrome Patients
ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
source: pixabay.com

ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment

According to a story from gurufocus.com, the biopharmaceutical company ADMA Biologics, Inc., has earned the 2020 BioNJ Innovator Award. This award was given as acknowledgement of the company's successful development…

Continue Reading ADMA Biologics Earns BioNJ 2020 Innovator Award for Primary Immunodeficiency Treatment
FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug
stevepb / Pixabay

FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug

According to a press release from the British-American biopharmaceutical company Orchard Therapeutics, the American Food and Drug Administration (FDA) has granted OTL-103, the Company's experimental Wiskott-Aldrich Syndrome drug, Regenerative Medicine…

Continue Reading FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug